Published in Cancer Weekly, December 27th, 1999
The draft guidelines recommend procedures to help ensure that NIH-funded human pluripotent stem cell research is conducted in an ethical and legal manner.
Such research promises new treatments and possible cures for many debilitating diseases and injuries, including Parkinson's, diabetes, heart disease, multiple sclerosis, burns, and spinal cord injuries. While the potential medical benefits of human stem cell technology are compelling and worthy of pursuit, the NIH believes that this area of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.